NEPHROS, INC. Sales Revenue, Goods, Gross (Deprecated 2018-01-31)
NEPHROS, INC. (NEPH) reported Sales Revenue, Goods, Gross (Deprecated 2018-01-31) of $637.00 thousand for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsGross · last filed 2011-08-15
- NEPHROS, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $637.00K, a 21.26% decline year-over-year.
- NEPHROS, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2010-06-30 was $809.00K.
| Period end | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 6 month |
|---|---|---|
| 2011-06-30 | $637.00K 10-Q · filed 2011-08-15 | $1.32M 10-Q · filed 2011-08-15 |
| 2010-06-30 | $809.00K 10-Q · filed 2011-08-15 | $1.80M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |